Bicalutamide in Treating Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: bicalutamide|OTHER: diagnostic laboratory biomarker analysis|OTHER: immunohistochemistry staining method
Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: National Cancer Institute (NCI)|AstraZeneca